Detection of allogeneic blood group A and B enzyme activities in patients with ABO incompatible kidney transplantation

Glycobiology

Volumn 20, Issue 10, 2010, Pages 1251-1258

  Tasaki, Masayuki ^a   Nakajima, Tamiko ^b   Imai, Naofumi ^a   Nakagawa, Yuki ^a   Saito, Kazuhide ^a   Takahashi, Kota ^a   Yazawa, Shin ^c,d  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

accommodation; blood group A and B antigens; blood group A and B enzymes; ELISA; incompatible kidney transplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ALPHA 1,3 N ACETYLGALACTOSAMINYLTRANSFERASE; ANTIBODY; AZATHIOPRINE; BASILIXIMAB; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N ACETYLGALACTOSAMINYLTRANSFERASE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; BLOOD GROUP TYPING; CLINICAL ARTICLE; CLINICAL DECISION MAKING; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; SERODIAGNOSIS;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; ANTIGEN-ANTIBODY REACTIONS; BLOOD GROUP INCOMPATIBILITY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALACTOSYLTRANSFERASES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOENZYME TECHNIQUES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956507637     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq086     Document Type: Article

References (29)

1. Asao T, Kuwano H, Nakamura J, Okamura A, Berger EG, Matta KL, Yazawa S. 2001. Tumor cells as the origin of elevated serum α1,3fucosyltransferase in associated with malignancy. Clin Exp Metastasis. 18:605.
2. Barbolla L, Mojena M, Cienfuegos JA, Escartin P. 1988. Presence of an inhibitor of glycosyltransferase activity in a patient following an ABO incompatible liver transplant. Br J Haematol. 69:93-96.
3. Daniels G. 1995. ABO, Hh and Lewis blood group systems. Human Blood Groups. London: Blackwell Science Ltd. p. 8-120.
4. Galili U. 2006. Xenotransplantation and ABO incompatible transplantation: The similarities they share. Transfus Apher Sci. 35:45-58.
5. Genberg H, Kumlien G, Wennberg L, Berg U, Tyden G. 2008. ABO-incompatible kidney transplantation using antigen-specific immunoadsorp-tion and rituximab: A 3-year follow-up. Transplantation. 85:1745-1754.
6. Hanto DW, Fectean AH, Alonso MH, Valente JF, Whiting JF. 2003. ABO-incompatible liver transplantation with no immunological graft loss using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transplant. 9:22-30.
7. Kominato Y, Fujikura T, Takizawa H, Hayashi K, Mori T, Matsue K, Yasue S, Matsuda T. 1990. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow. Exp Clin Immunogenet. 7:85-90.
8. Matsue K, Yasue S, Matsuda T, Iwabuchi K, Ohtsuka M, Ueda M, Kondo K, Shiobara S, Mori T, Koizumi S, et al. 1989. Plasma glycosyltransferase activity after ABO-incompatible bone marrow transplantation and development of an inhibitor for glycosyltransferase activity. Exp Hematol. 17:827-831.
9. Mojena M, Bosca L. 1989. Identification of an anti-A and anti-B blood group glycosyltransferase antibody after incompatible bone marrow transplant. Blood. 74:1134-1138.
10. Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, et al. 2009. ABO incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation. 87:1246-1255.
11. Rush D, Nickerson P, Gough J, McKenna R, Grimm P, Cheang M, Trpkov K, Solez K, Jeffery J. 1998. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol. 9:2129-2134.
12. 2 to O) kidney grafts. Transfus Med. 1:177-182.
13. Saito K, Nakagawa Y, Suwa M, Kumagai N, Tanikawa T, Nishiyama T, Ueno M, Gejyo F, Nishi S, Takahashi K. 2006. Pinpoint targeted immu-nosuppression: Anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation. 13:111-117.
14. Seno T, Tanaka M, Akamatsu S, Tachikawa T, Goto F, Furuta T, Yazawa S. 1997. A high sensitive enzyme-linked immunosorbent assay method for blood group A and B transferase activities using H-disaccharide. Jpn J Transf Med. 43:868-876.
15. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, et al. 2008. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 8:753-760.
16. Tachikawa T, Yazawa S, Asao T, Shin S, Yanaihara N. 1991. Novel method for quantifying α(1-3)-L-fucosyltransferase activity in serum. Clin Chem. 37:2081-2086.
17. Takahashi K. 2004. Accommodation in ABO-incompatible kidney transplantation: Why do kidney drafts survive? Transplant Proc. 36:193S-196S.
18. Takahashi K, Saito K, Takahara S, Okuyama A, Tanabe K, Toma H, Uchida K, Hasegawa A, Yoshimura N, Kamiryo Y. 2004. Japanese ABO-Incompatible Kidney Transplantation Committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant. 4:1089-1096.
19. Takahashi K, Saito K. 2006. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation. 13:118-122.
20. Takahashi K. 2007a. Recent findings in ABO-incompatible kidney transplantation: Classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment ofaccommodation. Clin Exp Nephrol.11:128-141.
21. Takahashi K. 2007b. ABO-Incompatible Kidney Transplantation. Establishing a Scientific Framework. Amsterdam, The Netherlands: Elsevier.
22. Takahashi K, Saito K, Nakazawa Y, Tasaki M, Hara N, Imai N. 2010. Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: Which anti-A/anti-B antibodies are responsible, natural or de novo? Transplantation. 89:635-637.
23. Tanabe K. 2007. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation. 84:S4-S7.
24. Tasaki M, Yoshida Y, Miyamoto M, Nameta M, Cuellar LM, Xu B, Zhang Y, Yaoita E, Nakagawa Y, Saito K, et al. 2009. Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney. Transplantation. 87:1125-1133.
25. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. 1990. Molecular genetic basis of the histo-blood-group ABO system. Nature. 345:229-233.
26. Yazawa S, Takeya A, Hosomi O, Nakajima T, Shimoda N, Ohi H, Tachikawa T, Piscorz CF, Jain RK, Matta KL. 1992. Use of synthetic H disaccharides as acceptors for detecting activities of UDP-GalNAc:Fuc alpha1-2Gal beta-R alpha1-3-N-acetylgalactosaminyltransferase in plasma samples from blood group A subgroups. Clin Chem. 38:2392-2395.
27. Yazawa S, Nakajima T, Kameyama N, Saga K, Tachikawa T. 1993. An enzyme-linked immunosorbent assay for blood-group A and B enzymes. Carbohydr Res. 239:329-335.
28. Yoshida A, Schmidt GM, Blume KG, Beulter E. 1980. Plasma blood group glycosyltransferase activities after bone marrow transplantation. Blood. 55:699-701.
29. Watkins WM. 1995. Biosynthesis 5. Molecular basis of antigenic specificity in the ABO, H and Lewis blood-group antigens. In: Montreul J, Vliegenthart JFG and Schachter H, editors. Glycoproteins. Amsterdam, The Netherlands: Elsevier. p. 313-390.